COVID-19 & Psoriasis Resource Center

To assist dermatologists and the patients they serve, the IPC is collecting information from around the world on coronavirus and psoriasis. If you have a resource on COVID-19 and psoriasis to add, please submit it to IPC.

Latest news on COVID-19 & Psoriasis

PsoProtect Registry Data Update

September 13, 2021

July Update on PsoProtect Registry Data

July 12, 2021

Expert Opinion: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based study

July 07, 2021

New data from the PsoProtect Registry

June 01, 2021

IPC Statement on COVID-19 & PsoriasisIPC's statement provides general guidance to physicians treating psoriasis patients based on the current understanding of the impact of COVID-19 and psoriasis.

Expert Opinions

Hear from world psoriasis experts their take on the most current publications on COVID-19.

Stories from the Field View videos and read interviews from some of IPC's experts regarding the impact on psoriasis care during the COVID-19 pandemic.

Treatment GuidelinesView recommendations from professional and patient societies around the globe that have provided additional information regarding treating patients with psoriasis during the COVID-19 pandemic.

PsoProtect Registry

Help us learn more about the impact on psoriasis and COVID-19 by participating in this global registry. You can submit a case on-line.

Key Publications Review articles on COVID-19 selected by IPC's Chief Medical Officer.

IPC STATEMENT
on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.

READ FULL STATEMENT

The National Psoriasis Foundation
COVID-19 Task Force Guidance Statements

Twenty-five key recommendations for the management of patients with psoriatic disease during the COVID-19 pandemic.

READ STATEMENTS

THIS WEEKS' PUBLICATIONS ON COVID-19 & PSORIASIS

Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine
No abstract

COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
No abstract

Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases
No abstract

Guttate flare in a patient with chronic plaque psoriasis following COVID-19 infection: A case report
No abstract

A case of de novo generalised pustular psoriasis following Oxford-AstraZeneca COVID-19 Vaccine
Dear Editor, Various cutaneous manifestations have been reported with COVID-19 infections during the pandemic, with some reports of new onset or flares of pre-existing skin disease after roll out of the vaccination programmes¹ . We present a case of new onset generalised pustular psoriasis felt to be secondary to the Oxford-AstraZeneca COVID-19 vaccine.

VIEW ALL ON PUBMED

RECOURCES FROM OUR INDUSTRY PARTNERS

AbbVie
Amgen
Novartis
UCB